【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Urinary Catheters Overview 6
3 Products under Development 7
3.1 Urinary Catheters – Pipeline Products by Stage of Development 7
3.2 Urinary Catheters – Pipeline Products by Segment 8
3.3 Urinary Catheters – Pipeline Products by Territory 9
3.4 Urinary Catheters – Pipeline Products by Regulatory Path 10
3.5 Urinary Catheters – Pipeline Products by Estimated Approval Date 11
4 Urinary Catheters – Pipeline Products under Development by Companies 12
4.1 Urinary Catheters Companies – Pipeline Products by Stage of Development 12
4.2 Urinary Catheters – Pipeline Products by Stage of Development 13
5 Urinary Catheters Companies and Product Overview 14
5.1 Applied Catheter Technologies Inc. Company Overview 14
5.1.1 Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 15
5.2.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Enox Biopharma, Inc Company Overview 16
5.3.1 Enox Biopharma, Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 FocusStart LLC Company Overview 17
5.4.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 Marvao Medical Devices Limited Company Overview 18
5.5.1 Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Olympus Medical Systems Corp. Company Overview 19
5.6.1 Olympus Medical Systems Corp. Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Sharklet Technologies, Inc. Company Overview 20
5.7.1 Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
5.8 Teleflex Incorporated Company Overview 21
5.8.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 21
5.9 The University of Utah Company Overview 23
5.9.1 The University of Utah Pipeline Products & Ongoing Clinical Trials Overview 23
5.10 University of California, San Diego Company Overview 24
5.10.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 24
5.11 University of Nottingham Company Overview 25
5.11.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 25
5.12 Urovalve, Inc. Company Overview 26
5.12.1 Urovalve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.13 Xennovate Medical LLC Company Overview 28
5.13.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 28
6 Urinary Catheters- Recent Developments 30
6.1 May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board 30
6.2 May 23, 2016: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 33
6.3 May 23, 2016: New Distribution Partnership for Edward-Elmhurst Health’s Physician Offices Results in Cost Savings of 10 Percent 33
6.4 May 16, 2016: Hollister Hires Carolin Archibald for Newly Created Position of Vice President of U.S. and Canada 34
6.5 May 13, 2016: ConvaTec Healthcare May Raise USD1 Billion in IPO 34
6.6 May 12, 2016: Bactiguard Holding: Interim Report For Q1 2016 34
6.7 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 36
6.8 May 04, 2016: C. R. Bard Prices Public Offering of 3% Notes Due 2026 for USD500 Million 36
6.9 May 04, 2016: Hollister Announces Settlement Agreement 36
6.10 May 03, 2016: Coloplast delivers H1 result in line with expectations 37
6.11 Apr 28, 2016: Teleflex Reports First Quarter 2016 Results 37
6.12 Apr 27, 2016: Bard Announces First Quarter Results 39
6.13 Apr 18, 2016: Henry Ford Breast Cancer Program Granted 3-Year Accreditation 39
6.14 Apr 05, 2016: Allegiance Health Joins Henry Ford Health System 40
6.15 Mar 09, 2016: Coloplast gets breakthrough with continence business in Japan 40
6.16 Feb 25, 2016: Teleflex Reports Fourth Quarter and Full Year 2015 Results; Provides 2016 Guidance 41
6.17 Feb 02, 2016: Coloplast delivers Q1 results in line with guidance 42
6.18 Jan 29, 2016: Bard Announces Fourth Quarter Results 43
6.19 Jan 21, 2016: First order from China Announced By Bactiguard 44
6.20 Jan 19, 2016: Leading Medical Device Companies Select Brainshark to Drive Sales Productivity 44
6.21 Jan 05, 2016: Argon Medical Devices Acquires Three Vascular Products from Rex Medical 45
6.22 Jan 05, 2016: Kane Biotech appoints new CFO and announces addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options 45
6.23 Jan 04, 2016: Product approval opens door to China 46
6.24 Dec 23, 2015: Coloplast settles with the U.S. Department of Justice 46
6.25 Dec 09, 2015: Bactiguard Holding : Major Order from India 47
6.26 Dec 09, 2015: Bactiguard Holding: Large Clinical Study Starting in India 47
6.27 Dec 07, 2015: Comfort Medical Acquires Medical Direct Club 48
6.28 Nov 30, 2015: Covalon Announces FDA Clearance for Its New SilverCoat Silicone Foley Catheter 48
6.29 Nov 30, 2015: Teleflex to focus on showcasing its Intraosseous and Central Vascular Access portfolio featuring chlorhexidine based technologies at GAVeCeLT 2015 – December 1-3, in Milan, Italy 48
6.30 Nov 03, 2015: Coloplast delivers full-year results in line with guidance 49
6.31 Oct 29, 2015: Teleflex Reports Third Quarter 2015 Results 50
6.32 Oct 22, 2015: Bard Announces Third Quarter Results 51
6.33 Oct 20, 2015: ConvaTec Introduces GentleCath Pro Closed-System Intermittent Catheter 51
6.34 Oct 02, 2015: Ambu announces partnership with Coloplast on visualization product for the urology market 52
6.35 Sep 15, 2015: Coloplast Launches New Continence Care Product – Speedicath Compact Male – in the United States 52
6.36 Aug 17, 2015: Teleflex Signs New Agreement with Amerinet for Surgical Instruments 53
6.37 Jul 30, 2015: Teleflex Reports Second Quarter 2015 Results 53
6.38 Jul 23, 2015: Bard Announces Second Quarter Results 54
6.39 Jul 21, 2015: FDA Issues Warning Letter To C. R. Bard 55
6.40 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 55
6.41 Jun 24, 2015: Innovative Duette Urinary Drainage System to be Featured at APIC Annual Meeting 56
7 Appendix 58
7.1 Methodology 58
7.2 About GlobalData 60
7.3 Contact Us 61
7.4 Disclaimer 61
【レポート販売概要】
■ タイトル:世界の尿路カテーテル市場:医療機器パイプライン分析2016■ 英文:Urinary Catheters - Medical Devices Pipeline Assessment, 2016
■ 発行日:2016年6月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0201EPD
■ 調査対象地域:グローバル
- 鉱業用潤滑剤の世界市場予測(~2022年)“The global mining lubricants market is projected to grow at a CAGR of 4.5% from 2017 to 2022” The mining lubricants market was valued at USD 1.95 billion in 2016, and is projected to reach USD 2.56 billion by 2022, at a CAGR of 4.5% from 2017 to 2022. The growth of the mining lubricants market is driven by the increasing demand from the Asia-Pacific region and growing end use industries, such as …
- ITシステム管理のグローバル市場:技術及び市場動向Summary This strategic focus report analyses the current trends, drivers, and inhibitors impacting the IT systems management market. The report outlines the evolution of IT systems management technologies, and identifies and assesses the best performing vendors in the market. This report also presents Kable’s view of the revenue opportunities in the IT systems management market through to 2018, hi …
- 瘢痕治療の世界市場2016-2020About Scar Treatment A scar is a patch of fibrous tissue (containing a protein called collagen) that is formed over a wound as a consequence of the body's natural healing process. Scars are classified into keloid scars, contracture scars, hypertrophic scars, and atrophic scars based on the composition of collagen and appearance. Many non-invasive methods including chemical and physical treatment a …
- DNSファイアウォールの世界市場:導入タイプ別(クラウド、オンプレミス、仮想アプライアンス)、エンドユーザー別(DNSプロバイダー、ドメイン名登録業者、企業、Webサイトホスト、サービスプロバイダー)、最終用途産業別(BFSI、テレコム・IT、メディア・エンターテイメント、小売・電子商取引、ヘルスケア、政府機関、教育)、地域別予測Global DNS Firewall Market to reach USD 242.4 million by 2025. Global DNS Firewall Market valued approximately USD 71.1 million in 2016 is anticipated to grow with a healthy growth rate of more than 14.6% over the forecast period 2017-2025. The extreme vulnerability of DNS to malware and Advanced Persistent Threat (APT) intrusions is one of the factors expected to drive the market. The objective o …
- Hemorrhagic Shock:グローバル臨床試験レビューH2, 2013Hemorrhagic Shock Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hemorrhagic Shock Global Clinical Trials Review, H2, 2013" provides data on the Hemorrhagic Shock clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhagic Shock. It includes an overview of the trial numbers and their recruitment s …
- [Updated] 世界のeClinical (臨床試験電子化)ソリューション市場動向(~2018)The global eClinical solutions market is estimated to grow at a CAGR of 13.5% and is expected to reach ~$5 billion by 2018. Compared to matured markets, the Asia-Pacific region is expected to grow at the highest CAGR of 19.5%. The growth of the eClinical solutions market is primarily triggered by factors such as, growth in the number of clinical trials, increasing government pressure to reduce the …
- 自動車アンテナモジュールの世界市場2016-2020About Antennas Antennas are the necessary component of any wireless communication system. Hence, they are considered as an ideal fitment for vehicles and are most often fitted in passenger cars owing to rising wireless content in the segment. The rising preference of customers toward driving pleasure and safety is pushing the adoption of wireless connectivity through antennas among outreach segmen …
- インシデント対応の世界市場:コンポーネント別(ソリューション、サービス)、サービス別、セキュリティタイプ別、導入モード別、組織規模別、地域別予測Global Incident Response Market to reach USD 48 billion by 2025. Global Incident Response Market valued approximately USD 9.30 billion in 2016 is anticipated to grow with a healthy growth rate of more than 20% over the forecast period 2017-2025. Stringent government regulations and compliances requirements, growing level of cyber-attacks, and heavy financial losses post incident occurrence have le …
- コールドチェーン物流のアジア太平洋市場:業務種類別、エンドユーズ産業別、製品別、技術別Cold chain logistics is a temperature-controlled supply chain that is an uninterrupted chain of distribution and storage activity in which a given temperature is maintained throughout the chain. This type of logistics is used to ensure and extend the life of the goods and products such as seafood, frozen food, agriculture produce, chemicals, photographic film, pharmaceutical drugs, and others. Mon …
- M2Mマネージドサービスプロバイダ市場(Telecom Managed Services: The Market for Machine-to-Machine (M2M) Managed Service Providers)Machine-to-machine (M2M) communications is a technology that is transforming the way that business is conducted, impacting everything from traditional telephony and IT operations to ERP, SCM, public safety, homeland security, and more. Traditionally the realm of utilities and SCADA systems, M2M is expanding into many new industries, market segments, applications, and use cases. Several new areas h …
- 無線LANセキュリティの世界市場2016-2020About the Wireless LAN Security Market WLAN is a wireless Ethernet connectivity between client devices such as desktops computers, PDAs, and the wireless hub connected to the physical network. WLANs follow the wired network's traditional hub-spoke configuration and consists of the following two components including wireless clients and APs. The growth in the market is because of the adoption of sm …
- 自己免疫疾患診断の世界市場の規模および予測:タイプ別(全身性自己免疫疾患診断、局所自己免疫疾患診断)、地域別、動向の分析 2014-2025The global autoimmune disease diagnostics market is expected to reach a value of USD 5.0 billion by 2025, based on a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for …
- Late-Stage Chronic Kidney Disease (CKD):市場分析及び予測(~2017)OpportunityAnalyzer: Late-Stage Chronic Kidney Disease (CKD) - Opportunity Analysis and Forecasts to 2017 Summary Late-stage chronic kidney disease (CKD), encompassing stage 4 and 5 CKD, is a disease that manifests in a host of co-morbidities. Of these, bone and mineral metabolism disorders are some of the most commonly treated and have significant impact on morbidity and mortality of patients. Th …
- Erbitux:大腸癌治療薬市場分析Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on h …
- 世界のアルコール飲料(酒類)市場:ビール、ワイン、スピリッツ、ウイスキー、白酒(中国)、ウォッカ、ラム酒などAbout Alcoholic Drinks Alcoholic drinks comprise beer, spirits, and wine. In 2013, the Beer segment led the market with 53.24 percent and 75.34 percent share, respectively, in terms of revenue and volume. An increase in the demand among millennial population in the US, growing demand for premium alcoholic beverages, and increased marketing and promotions by vendors drive the consumption and sales …